Publications by authors named "Winnie Yao"

Article Synopsis
  • Low intra-tumor heterogeneity (ITH) is linked to better patient survival and response to immunotherapy, but the role of immune factors in tumor aggressiveness remains unclear.
  • Researchers studied immune escape mechanisms in mouse tumors with low ITH, finding non-rejected clones had more tumor-associated macrophages and T-cell exhaustion compared to rejected ones.
  • They identified Mif as a key factor in immune rejection; knocking it out led to smaller tumors and lower macrophage infiltration, a finding that was supported by data from melanoma patients.
View Article and Find Full Text PDF

Tumor metastasis requires systemic remodeling of distant organ microenvironments that impacts immune cell phenotypes, population structure, and intercellular communication. However, our understanding of immune phenotypic dynamics in the metastatic niche remains incomplete. Here, we longitudinally assayed lung immune transcriptional profiles in the polyomavirus middle T antigen (PyMT) and 4T1 metastatic breast cancer models from primary tumorigenesis, through pre-metastatic niche formation, to the final stages of metastatic outgrowth at single-cell resolution.

View Article and Find Full Text PDF

Decreased intra-tumor heterogeneity (ITH) correlates with increased patient survival and immunotherapy response. However, even highly homogenous tumors may display variability in their aggressiveness, and how immunologic-factors impinge on their aggressiveness remains understudied. Here we studied the mechanisms responsible for the immune-escape of murine tumors with low ITH.

View Article and Find Full Text PDF

Clonal hematopoiesis of indeterminate potential (CHIP) is a premalignant expansion of mutated hematopoietic stem cells. As CHIP-associated mutations are known to alter the development and function of myeloid cells, we hypothesized that CHIP may also be associated with the risk of Alzheimer's disease (AD), a disease in which brain-resident myeloid cells are thought to have a major role. To perform association tests between CHIP and AD dementia, we analyzed blood DNA sequencing data from 1,362 individuals with AD and 4,368 individuals without AD.

View Article and Find Full Text PDF

Individual elements within a superenhancer can act in a cooperative or temporal manner, but the underlying mechanisms remain obscure. We recently identified an superenhancer, within which different elements act at distinct stages of type 1 classical dendritic cell (cDC1) development. The +41-kb enhancer is required for pre-cDC1 specification, while the +32-kb enhancer acts to support subsequent cDC1 maturation.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-GD2 antibody immunotherapy has improved outcomes for high-risk neuroblastoma in children, but nearly 50% of patients still relapse, highlighting a need to understand resistance mechanisms.
  • Research shows that lower GD2 expression is linked to a mesenchymal cell state in neuroblastoma, leading to decreased sensitivity to anti-GD2 therapy due to reduced expression of the enzyme ST8SIA1, which is crucial for GD2 synthesis.
  • Targeting the EZH2 enzyme with pharmacological inhibitors can restore GD2 expression and re-sensitize mesenchymal neuroblastoma cells to anti-GD2 therapy, suggesting a potential combined treatment strategy to improve patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • T cell exhaustion hampers the body's ability to fight tumors, and this study investigates genetic factors influencing this process using CRISPR-Cas9 screenings.
  • Researchers found that certain chromatin remodeling complexes, specifically INO80 and BAF, play a crucial role in T cell persistence and function in tumors.
  • By depleting the BAF complex member Arid1a, the study showed that T cells maintained their active state and improved their effectiveness against cancer, highlighting a potential strategy for enhancing cancer immunotherapy.
View Article and Find Full Text PDF

Understanding the cellular regulation of tumor-specific CD8 T-cell responses is critical to designing improved clinical strategies for cancer immunotherapy. In this issue, Aoki and colleagues deepen our knowledge of this topic by demonstrating that transient depletion of CD4 T cells in patients with gastrointestinal cancer induces remodeling of the T-cell repertoire, including clonal replacement and expansion of CD8 T-cell clones shared between the blood and tumor..

View Article and Find Full Text PDF

Experimental autoimmune encephalomyelitis is a model for multiple sclerosis. Here we show that induction generates successive waves of clonally expanded CD4, CD8 and γδ T cells in the blood and central nervous system, similar to gluten-challenge studies of patients with coeliac disease. We also find major expansions of CD8 T cells in patients with multiple sclerosis.

View Article and Find Full Text PDF